摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-二氮杂萘硫醇 | 16015-46-6

中文名称
1-二氮杂萘硫醇
中文别名
——
英文名称
1(2H)-phthalazinethione
英文别名
Phthalazine-1-thione;phthalazin-1-thione;2H-phthalazine-1-thione;2H-Phthalazin-1-thion;1(2H)-Phthalazinthion;Phthalazthion;2H-phthalazine-1-thione
1-二氮杂萘硫醇化学式
CAS
16015-46-6
化学式
C8H6N2S
mdl
MFCD01918266
分子量
162.215
InChiKey
RGYHGSBVFWRLCJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    163-167°C
  • 溶解度:
    溶于氯仿、二氯甲烷、DMSO、甲醇

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    56.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090

SDS

SDS:cd0800255fa34c7e48c3c5f6dbadd373
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] HETEROCYCLIC COMPOUNDS THAT BLOCK THE EFFECTS OF ADVANCED GLYCATION END PRODUCTS (AGE)<br/>[FR] COMPOSES HETEROCYCLIQUES BLOQUANT LES EFFETS DES PRODUITS TERMINAUX AVANCES DE GLYCATION
    申请人:REDDYS LAB LTD DR
    公开号:WO2005040163A1
    公开(公告)日:2005-05-06
    The present invention relates to novel compounds of Formula (Ia) or (Ib), their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. Formula (Ia), or Formula (Ib) in the above formulae L represents Formula (I), Formula (II) or -(CH2)1- Q represents Formula (III), or Formula (IV). The present invention also relates to a process for the preparation of the above said novel compounds, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to methods and compositions comprising compounds that treat pathophysiological conditions arising from inflammatory responses. In particular, the present invention is directed to compounds that inhibit or block glycated protein produced induction of the signaling-associated inflammatory responses in tissues, including endothelial cells. The present invention relates to compounds that inhibit smooth muscle proliferation. The present invention also relates to compounds that act as modulators of Perlecan activity and expression. In particular, the present invention is directed to compounds that inhibit smooth muscle cell proliferation by modulating heparan sulfate proteoglycans (HSPG) such as Perlecan. The present invention further relates to the use of compounds to treat vascular occlusive conditions characterized by smooth muscle proliferation such as stenosis, restenosis, neointimal hyperplasia, and atherosclerosis. The compounds of Formula (I) are also useful for the treatment and/or prevention of cancer. The types of cancers include melanoma, prostate, leukemia, lymphoma, non-small lung cancers, cancer of the central nervous system, breast, colon, ovarian or renal cancer.
    本发明涉及公式(Ia)或(Ib)的新化合物,它们的药学上可接受的盐以及含有它们的药学上可接受的组合物。在上述公式中,公式(Ia)或公式(Ib)中的L代表公式(I)、公式(II)或-(CH2)1-,Q代表公式(III)或公式(IV)。本发明还涉及制备上述新化合物、其药学上可接受的盐和含有它们的药物组合物的方法。本发明还涉及包括治疗由炎症反应引起的病理生理条件的化合物的方法和组合物。具体而言,本发明涉及抑制或阻断组织中糖化蛋白诱导的与信号相关的炎症反应的化合物。本发明涉及抑制平滑肌增殖的化合物。本发明还涉及作为Perlecan活性和表达调节剂的化合物。具体而言,本发明涉及通过调节肝素硫酸蛋白聚糖(HSPG)如Perlecan来抑制平滑肌细胞增殖的化合物。本发明进一步涉及利用化合物治疗由平滑肌增殖特征的血管闭塞性疾病,如狭窄、再狭窄、新内膜增生和动脉粥样硬化。公式(I)的化合物也可用于治疗和/或预防癌症。癌症类型包括黑色素瘤、前列腺癌、白血病、淋巴瘤、非小细胞肺癌、中枢神经系统癌症、乳腺癌、结肠癌、卵巢癌或肾癌。
  • Photoaddition of Olefins to Quinolin-, Isoquinolin-, and Phthalazin-thione Systems
    作者:Eisuke Sato、Yoshiya Ikeda、Yuichi Kanaoka
    DOI:10.1246/cl.1987.273
    日期:1987.2.5
    Irradiation of quinolin-2-, isoquinolin-1-, and phthalazin-1-thiones with olefins afforded photoaddition products: substituted quinolines, isoquinolines and phthalazines at the thiocarbonyl carbon. A new addition-cyclization was found producing tricyclic thiopyrano-isoquinolines and -phthalazines.
    用烯烃辐照 quinolin-2-、isoquinolin-1- 和 phthalazin-1-thiones 提供光加成产物:取代的喹啉、异喹啉和酞嗪在硫代羰基碳上。发现了一种新的加成环化反应,产生了三环吡喃并异喹啉和 -酞嗪。
  • Photochemistry of conjugated nitrogen-thiocarbonyl systems. VII. Photoaddition of quinoline-, isoquinoline- and phthalazine-thione systems to olefins.
    作者:Eisuke SATO、Yoshiya IKEDA、Yuichi KANAOKA
    DOI:10.1248/cpb.38.1205
    日期:——
    Photolyses of quinoline-2-thiones (1A, B), isoquinoline-1-thione (14A), and phthalazine-1-thiones (14B-D) in the presence of olefins (2) afforded photoaddition products such as substituted quinolines, isoquinolines, phthalazines, and novel tricyclic products, probably by way of thietanes formed by photoaddition of olefins to the C=S bond.
    喹啉-2-硫酮(1A、B)、异喹啉-1-硫酮(14A)以及酞嗪硫酮(14B-D)在烯烃(2)存在下的光解反应,通过烯烃对C=S键的光加成可能形成的硫杂环丁烷途径,提供了取代的喹啉、异喹啉、酞嗪及新型三环产物。
  • Phtalazin derivatives and their use as pesticides
    申请人:RHONE POULENC AGRICULTURE LTD.
    公开号:EP0634404A1
    公开(公告)日:1995-01-18
    The invention provides compounds of formula:    wherein the symbols are as defined in the description, which possess utility as pesticides (e.g. herbicides and insecticides).
    这项发明提供了以下结构的化合物:   其中符号如描述中所定义,具有作为农药(例如除草剂和杀虫剂)的效用。
  • Carbenoid intermediates in the synthesis of mesoionic anhydro-4-hydroxythiazolium hydroxides
    作者:Kevin T. Potts、Peter Murphy
    DOI:10.1039/c39840001348
    日期:——
    α-(Tosylhydrazono)phenylacetyl chloride and N-Monosubstituted thioamides in dry, non-protic solvents and in the presence of Et3N give representatives of the title mesoionic ring system in good to excellent yields; carbene or carbenoid type intermediates are most likely involved in these regiospecific cyclizations.
    在干燥的非质子溶剂中和在Et 3 N存在下,α-(甲苯磺酰肼基)苯基乙酰氯和N-单取代的硫代酰胺以良好至极好的收率代表了标题的中离子环体系;卡宾或类胡萝卜素类中间体最有可能参与这些区域特异性环化反应。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台